White Paper

Reimagining DNA Payloads; Enzymatic Circular DNA For The Next Generation Of Gene Editing

Source: Touchlight

By Mitchell Brun, Ph.D. Lisa Caproni, Ph.D., and Milica Vukovic, Ph.D MBA.

GettyImages-481911027-mrna-3d-structure-dna-helix

This piece explores how innovative circular DNA architectures are reshaping gene editing by providing more efficient, flexible, and safer payload options for a wide range of insertion technologies. As therapeutic programs evolve beyond simple edits toward large and complex gene insertions, traditional templates—whether viral or linear DNA—struggle with cytotoxicity, payload limitations, and manufacturing constraints. Newly developed circular DNA formats, incorporating customizable single‑stranded and double‑stranded regions, address these challenges by improving stability, reducing innate immune activation, and enabling high‑efficiency integration. These architectures support diverse mechanisms including homology‑directed repair, recombination, transposition, and hybrid CRISPR‑based systems. Their design helps maintain cell viability, minimise inflammatory signaling, and accommodate multi‑kilobase sequences required for next‑generation therapies. Scalable enzymatic manufacturing allows rapid production of high‑purity templates without fermentation‑derived contaminants, enabling smooth progression from research through GMP‑ready applications. Collectively, these advancements redefine payload engineering and pave the way for safer, more adaptable non‑viral gene editing strategies.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma